These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2080231)
1. Examination of the potential antiulcer activity of the calcium antagonist propyl-methylenedioxyindene. III. Lack of effect on cysteamine-induced duodenal ulcers in rats. Wong WS; Rahwan RG; Stephens RL Pharmacology; 1990; 41(4):215-23. PubMed ID: 2080231 [TBL] [Abstract][Full Text] [Related]
2. Antiulcer activity of the calcium antagonist propyl-methylenedioxyindene--II. Effects on acid secretion and gastric emptying in rats. Wong WS; Rahwan RG Gen Pharmacol; 1990; 21(3):327-31. PubMed ID: 2341020 [TBL] [Abstract][Full Text] [Related]
3. Pirenzepine prevents cysteamine-induced formation of gastroduodenal ulcers and reduction of mesenteric circulation. Bernardini MC; Blandizzi C; Morini G; Chiavarini M; Impicciatore M; Del Tacca M Arch Int Pharmacodyn Ther; 1989; 302():242-54. PubMed ID: 2636820 [TBL] [Abstract][Full Text] [Related]
4. Antiulcer activity of the calcium antagonist propyl-methylenedioxyindene--I. Effect on cold/restraint stress-induced ulcers in rats. Wong WS; Rahwan RG Gen Pharmacol; 1990; 21(3):321-5. PubMed ID: 2341019 [TBL] [Abstract][Full Text] [Related]
5. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat. Borella LE; DiJoseph JF; Mir GN Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181 [TBL] [Abstract][Full Text] [Related]
6. Antiulcer activity of the calcium antagonist propyl-methylenedioxyindene--V. Localization of site of action. Stephens RL; Rahwan RG Gen Pharmacol; 1992 Mar; 23(2):193-6. PubMed ID: 1639231 [TBL] [Abstract][Full Text] [Related]
7. Antiulcer activity of the calcium antagonist propyl-methylenedioxyindene. IV. Effects on gastric lesions in rats induced by cold-restraint stress and thyrotropin-releasing hormone. Wong WS; Rahwan RG; Stephens RL Life Sci; 1990; 47(16):1483-9. PubMed ID: 2123509 [TBL] [Abstract][Full Text] [Related]
8. Effect of pentobarbital anesthesia and bile acids on cysteamine-induced duodenal and gastric ulcers in rats. Schwedes U; Clémençon GH; Paschke R; Usadel KH Scand J Gastroenterol Suppl; 1984; 92():121-4. PubMed ID: 6146197 [TBL] [Abstract][Full Text] [Related]
9. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers. Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535 [TBL] [Abstract][Full Text] [Related]
10. The effect of verapamil on cysteamine-induced duodenal ulcer in the rat. Lee CK; Yim DS; Kim WH J Korean Med Sci; 1987 Dec; 2(4):247-53. PubMed ID: 3268182 [TBL] [Abstract][Full Text] [Related]
11. Influence of various factors and drugs on cysteamine-induced duodenal ulcers in the rat. Fujii Y; Ishii Y Jpn J Pharmacol; 1975 Dec; 25(6):663-70. PubMed ID: 1228251 [TBL] [Abstract][Full Text] [Related]
12. Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy. Bedekovic V; Mise S; Anic T; Staresinic M; Gjurasin M; Kopljar M; Kalogjera L; Drvis P; Boban Blagaic A; Batelja L; Seiwerth S; Sikiric P Eur J Pharmacol; 2003 Sep; 477(1):73-80. PubMed ID: 14512101 [TBL] [Abstract][Full Text] [Related]
13. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats. Tariq M; Parmar NS; Ageel AM J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816 [TBL] [Abstract][Full Text] [Related]
14. Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats. Takeuchi K; Nishiwaki H; Okabe S Dig Dis Sci; 1987 Mar; 32(3):295-304. PubMed ID: 3816483 [TBL] [Abstract][Full Text] [Related]
15. Hymenaea stigonocarpa Mart. ex Hayne: a Brazilian medicinal plant with gastric and duodenal anti-ulcer and antidiarrheal effects in experimental rodent models. Rodrigues Orsi P; Bonamin F; Aparecida Severi J; Cássia Santos R; Vilegas W; Hiruma-Lima CA; Stasi LC J Ethnopharmacol; 2012 Aug; 143(1):81-90. PubMed ID: 22750452 [TBL] [Abstract][Full Text] [Related]
16. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration. Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169 [TBL] [Abstract][Full Text] [Related]
17. The effect of intracisternally administered bombesin on cysteamine-induced duodenal ulcers in rats. Hernandez DE; Adcock JW; Nemeroff CB; Prange AJ Eur J Pharmacol; 1982 Oct; 84(3-4):205-9. PubMed ID: 7173320 [TBL] [Abstract][Full Text] [Related]
18. Effect of nitrofurans on duodenal ulceration induced by cysteamine or indometacin. Ali BH Pharmacology; 1991; 42(1):49-53. PubMed ID: 2057520 [TBL] [Abstract][Full Text] [Related]
19. Effect of elcatonin on experimental gastric and duodenal ulcers. Ohno H; Noguchi M; Takayanagi N Jpn J Pharmacol; 1985 Jan; 37(1):67-75. PubMed ID: 4039385 [TBL] [Abstract][Full Text] [Related]
20. 4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from that of cimetidine. Morimoto Y; Shimohara K; Tanaka K; Hara H; Sukamoto T Jpn J Pharmacol; 1994 Mar; 64(3):221-4. PubMed ID: 8022123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]